Stocktoria

Rafael Holdings, Inc. RFL

NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Chart by TradingView
2/9
Piotroski F — financial health
0.8
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$30,000$637,000$279,000$410,000$802,000
Operating income-$29.2M-$102.6M-$15.0M-$60.5M-$28.2M
Net income-$30.5M-$34.4M-$1.9M-$124.7M-$23.1M
Operating cash flow-$18.9M-$7.8M-$10.9M-$26.0M-$15.3M
Free cash flow-$18.9M-$7.9M-$26.0M-$15.5M
Total assets$114.1M$96.8M$98.8M$118.3M$154.1M
Total liabilities$15.7M$10.6M$2.2M$21.1M$17.4M
Shareholders' equity$98.4M$86.3M$96.6M$97.2M$136.7M
Ratios
Operating margin-97196.7%-16111.0%-5391.8%-14750.5%-3516.1%
Net margin-101733.3%-5401.9%-672.4%-30404.4%-2875.4%
FCF margin-63093.3%-1247.3%-6351.2%-1935.2%
Return on assets-26.7%-35.5%-1.9%-105.4%-15.0%
Return on equity-31.0%-39.9%-1.9%-128.2%-16.9%
Current ratio4.899.6538.675.150.85
Revenue growth-95.3%128.3%-32.0%-48.9%-83.7%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC89,138$111,423

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 0.8 (distress)

  • Working capital / assets 0.395
  • Retained earnings / assets -2.035
  • EBIT / assets -0.256
  • Equity / liabilities 6.251

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001713863 · as of 2025-07-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.